Provided by Tiger Trade Technology Pte. Ltd.

Edwards Lifesciences

90.21
+0.26000.29%
Volume:2.04M
Turnover:184.25M
Market Cap:52.01B
PE:52.48
High:90.41
Open:89.98
Low:89.55
Close:89.95
52wk High:96.29
52wk Low:72.30
Shares:576.54M
Float Shares:575.03M
Volume Ratio:0.74
T/O Rate:0.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.72
EPS(LYR):1.83
ROE:9.18%
ROA:8.37%
PB:4.90
PE(LYR):49.22

Loading ...

Edwards Lifesciences Can Sustain Strong Revenue Growth on Technological Leadership, RBC Says

MT Newswires Live
·
Jun 30

Edwards Lifesciences Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 27

Edwards Lifesciences Posts Progress Trial Baseline Data on Moderate Aortic Stenosis Patients at New York Valves 2026

Reuters
·
Jun 26

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Edwards Lifesciences (EW), Encompass Health (EHC) and Moderna (MRNA)

TIPRANKS
·
Jun 26

Edwards Lifesciences Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 25

Movement Alert|Edwards Lifesciences Rises 3.53% in Regular Trading, CMS TAVR National Coverage Determination Memo Continues to Serve as Positive Catalyst

Market Focus
·
Jun 24

Carvolix raises EUR 10 million in private placement at EUR 3.36 per share

Reuters
·
Jun 24

Edwards Lifesciences Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jun 23

Edwards Lifesciences CEO Bernard Zovighian disposes of 523 common shares worth $45,979.16

Reuters
·
Jun 18

Edwards Lifesciences Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Jun 18

BTIG Sticks to Their Buy Rating for Edwards Lifesciences (EW)

TIPRANKS
·
Jun 17

Movement Alert|Edwards Lifesciences Rises 3.51% in Regular Trading, CMS Releases Favorable TAVR National Coverage Decision Memo

Market Focus
·
Jun 17

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

Reuters
·
Jun 17

Edwards Lifesciences Seen Benefiting From CMS Transcatheter Aortic Valve Replacement Rule, RBC Says

MT Newswires Live
·
Jun 16

Edwards Lifesciences Price Target Maintained With a $100.00/Share by RBC Capital

Dow Jones
·
Jun 16

Leerink ‘incrementally positive’ on Edwards Lifesciences after TAVR NCD proposal

TIPRANKS
·
Jun 16

RBC Capital Sticks to Its Buy Rating for Edwards Lifesciences (EW)

TIPRANKS
·
Jun 16

Edwards Lifesciences Buy Rating Reaffirmed as Favorable TAVR Policy Update Supports Growth and $100 Price Target Maintained

TIPRANKS
·
Jun 16

Analysts Conflicted on These Healthcare Names: Edwards Lifesciences (EW), Xencor (XNCR) and Definitive Healthcare Corp (DH)

TIPRANKS
·
Jun 16

Edwards Lifesciences Corp. Stock Rises Monday, Still Underperforms Market

Dow Jones
·
Jun 16